Aurobindo Pharma subsidiary Lyfius Pharma has resumed Penicillin-G production on receipt of Andhra Pradesh Pollution Control Board’s go ahead to operate the Kakinada plant whose operations were paused after a fire in April.
“Lyfius, a wholly owned stepdown subsidiary, has re-started the production with immediate effect after receiving the consent to operate from APPCB on June 29,” the parent company said in a filing on Sunday.
Following the fire incident on April 27, the company had said certain ancillary equipment were damaged and there was no impact to the core manufacturing infrastructure. “As a precautionary measure and to facilitate necessary equipment replacements, operations at the plant will be temporarily paused for an estimated period of 20-25 days,” it had said.
Last month, in an update, it said the preliminary assessment of loss is estimated around Rs.4 crore and Lyfius was in the process of submitting its final claim with the insurance company. It was also awaiting APPCB approval of the company’s renewal application for ‘consent to operate’.
Published – June 30, 2025 09:48 pm IST